Drugs / TJO-002
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03419975 | Apr 2016 → Dec 2017 | ocular hypertension, open-angle glaucoma | Taejoon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TJO-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03419975 ↗ |